Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test

NCT01785082 is registered in ClinicalTrials.gov with Humedics GmbH as lead sponsor.

NCT NCT01785082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01785082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test
Lead sponsor
Humedics GmbH
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2015
Enrollment
149 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure